Clinical Trial

A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After Chemotherapy

Name: A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After Chemotherapy — clinical trial record (NCT07628738)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is designed to evaluate the efficacy and safety of reduced-intensity radiotherapy for stage I/II low-risk nasal-type NK/T-cell lymphoma that has achieved complete remission after chemotherapy.

Trial Details

NCT Number	NCT07628738
Lead Sponsor	Ruijin Hospital
Conditions	Lymphoma (Non-Hodgkin's Lymphoma)
Enrollment	39 participants
Start Date	2026-07-01
Primary Completion	2032-05-01 (estimated)
Study Completion	2034-05-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-09